Found vs HealthRx: Biology-first care vs prepaid compounded plans
Found vs HealthRx: both offer online weight-loss care featuring semaglutide and tirzepatide options, but they differ sharply on personalization, pricing models, insurance, compounded medication framing, and shipping. Early verdict: Found emphasizes a biology-first personalized, medically supervised program with plans starting at $39 and broader insurance handling, while HealthRx centers on prepaid compounded plans from $99/month with overnight cold shipping and fixed plan pricing.
Explore Found biology-first plans
Key differences at a glance for Found vs HealthRx
This comparison focuses on the most distinctive supported differences: pricing and plan structure, insurance acceptance and handling, compounded medication status and regulatory notes, clinician review and personalization, and shipping and dose/renewal terms.
1. Pricing model and starting price
Found promotes affordable monthly plans and explicitly states you can “Get started for as low as $39” and notes plan pricing like “Found membership starts at $49/mo when billed annually” in captured materials. HealthRx advertises a lowest prepaid semaglutide option “from $99/month on a 12-month prepaid semaglutide plan ($1,163 today; $1,188 at renewal)” and tirzepatide plans start at $179/month. HealthRx also notes the lowest advertised monthly price requires a longer prepaid plan.
See HealthRx prepaid plan pricing
2. Insurance and cost handling
Found states “Most insurance now accepted,” claims to handle insurance paperwork and highlights programs such as a Medicare GLP-1 Bridge Program for eligible Part D members with specific caveats. HealthRx is explicit: “No insurance” for the advertised plan structure and frames compounded medication pricing as skipping the insurance billing layer. Both include qualifiers that actual coverage, pricing, and eligibility vary and are subject to clinician review.
3. Compounded medications and regulatory notes
Both providers present compounded semaglutide or tirzepatide options and include regulatory qualifiers. Found repeats: “Compounded GLP-1s are not FDA- approved or evaluated for safety or efficacy, and not available in all states.” HealthRx states: “Compounded medication is not FDA-approved. It is prepared by a licensed pharmacy for an individual patient with a valid prescription.” Found also presents multiple branded and compounded options and warns that certain medications are FDA-approved for conditions other than weight and that Found is not affiliated with trademark owners.
4. Clinician review, personalization, and program focus
Found emphasizes a biology-first, personalized medically supervised program that builds a plan around metabolic biology, hormones, blood sugar regulation, sleep, and behavioral factors. HealthRx emphasizes that “You are not picking a medication off a menu — the clinician reviewing your file decides whether semaglutide or tirzepatide is the right fit, or whether neither is.” Found positions broader program elements around lifestyle and biology beyond medication; HealthRx focuses on clinician-determined medication selection and the plan it ships on.
5. Shipping, dose adjustments, and renewal terms
HealthRx highlights overnight cold shipping with tracked, free shipping on every plan and that “Your plan price does not change when your dose does.” HealthRx also points out prepaid and renewal costs where the monthly effective price depends on plan length. Found discusses plan pricing, membership options, and insurance paperwork handling; captured evidence does not detail Found’s shipping promises in the source row.
| Criteria | Found | HealthRx |
|---|---|---|
| Starting price | Get started for as low as $39; membership examples include $49/mo billed annually | From $99/month on a 12-month prepaid semaglutide plan; tirzepatide from $179/month |
| Insurance | “Most insurance now accepted” and Found handles insurance paperwork; coverage varies | No insurance for advertised plans; compound pricing skips insurance billing layer |
| Compounded medication | Offers compounded semaglutide and tirzepatide; notes compounded GLP-1s are not FDA-approved | Compounded semaglutide or tirzepatide prepared per prescription; not FDA-approved |
| Personalization/clinician review | Biology-first personalized medically supervised program tailored to metabolic biology | Clinician reviews file to decide if semaglutide, tirzepatide, or neither is right |
| Shipping and dose pricing | Captured evidence does not specify shipping details; pricing and insurance terms vary | Overnight cold shipping; plan price does not change when dose changes; lowest price needs longer prepaid term |
Which provider fits your priorities: Found vs HealthRx
If you prioritize a broader medically supervised, biology-centered program and want a provider that manages insurance paperwork and promotes lower entry pricing, Found is the supported choice. If you prioritize predictable prepaid plan pricing, overnight cold shipping, and a clinician-determined medication delivered via a compounded pharmacy with no insurance billing, HealthRx matches those priorities according to captured details.
Compare Found personalized options
Review HealthRx shipping and plan terms
Start Found enrollment details
Bottom line on Found vs HealthRx
Found vs HealthRx diverge: Found emphasizes a biology-first, personalized medically supervised program with plans starting as low as $39 and broader insurance handling, while HealthRx emphasizes prepaid compounded semaglutide or tirzepatide plans from $99/month with overnight cold shipping and fixed plan pricing. Both include important regulatory qualifiers that compounded medications are not FDA-approved and that eligibility, pricing, insurance, and availability vary and are subject to clinician review.
Choose Found if you want weight-loss care built around metabolic biology, assistance with insurance paperwork, and lower advertised entry pricing. Choose HealthRx if you prefer prepaid compounded semaglutide or tirzepatide plans with overnight cold shipping and a clinician review that determines medication suitability.